|
|
We recruited 302 contributors between March 13 and October 15, 2014; 224 were randomized (149 intervention, seventy five controls) after finishing the baseline phase (Fig. 1). Previous to randomization 78 contributors discontinued, the first reason for this was failure to meet screening HbA1c criterion. Participants’ baseline traits are summarized in Table 1, the full evaluation set included 224 randomized members, and there were no important variations between teams. An analogous drop in HbA1c was detected in both teams comparing research end to baseline values. 0.0301 (Supplementary Material p. 0.0081 (Supplementary Material p. Significant reductions in all sensor measures of time spent in hypoglycemia, variety of events, and area beneath the curve had been observed for intervention participants in contrast with management (Table 2, Fig. 2, and Supplementary Material pp. Difference in intervention and management teams for time in vary and hypoglycemia measures. Quite a lot of glucose variability measures were explored and an enchancment for intervention participants was noticed (Table 2 and Supplementary Material pp. Glucose monitoring frequency (a) and whole variety of scans by time of day in the intervention group (b). Number of scans performed across all intervention contributors over 6 months by time of day.
My webpage :: BloodVitals home monitor |
|
發表於